pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
isaralgagene civaparvovec
isaralgagene civaparvovec [INN]
Fabry Disease
$SGMO
SANGAMO THERAPEUTICS, INC
0
catalysts
Phase 2
isomiosamine
isomiosamine [INN]
Sarcopenia
$QCLS
Q/C TECHNOLOGIES, INC.
0
catalysts
Phase 2
istaroxime
istaroxime [INN]
Acute Heart Failure
Windtree Therapeutics Inc
0
catalysts
← prev
page 41 of 53
next →
131
Pain
89
Neurology
1
Phase 2
isuzinaxib
isuzinaxib [INN]
Acute Renal Failure (ARF) (Acute Kidney Injury)
AptaBio Therapeutics Inc
0
catalysts
Phase 2
it-hMSC
Ageing
Stemedica Cell Technologies Inc
0
catalysts
Phase 2
itanapraced
itanapraced [INN]
Mild Cognitive Impairment
CereSpir Inc
0
catalysts
Phase 2
itruvone
Major Depressive Disorder
$VTGN
Vistagen Therapeutics, Inc.
0
catalysts
Phase 2
ivaltinostat
ivaltinostat [INN]
Pancreatic Ductal Adenocarcinoma
CG Invites Co Ltd
0
catalysts
Phase 2
ketoprofen
Topofen (ketoprofen)
Arthralgia (Joint Pain)
Cyclooxygenase
Achelios Therapeutics Inc
0
catalysts
Phase 2
lacutamab
lacutamab [INN]
Anaplastic Large Cell Lymphoma (ALCL)
$IPHA
Innate Pharma SA
0
catalysts
Phase 2
laromestrocel
laromestrocel [INN]
Alzheimer's Disease
$LGVN
Longeveron Inc.
0
catalysts
Phase 2
lasmecabtagene timgedleucel
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Cellectis SA
0
catalysts
Phase 2
latanoprost SR
Xalatan (latanoprost)
Open-Angle Glaucoma
Prostaglandin F2-alpha receptor
BioLight Israeli Life Sciences Ltd
0
catalysts
Phase 2
lenacapavir + teropavimab + zinlirvimab
Human Immunodeficiency Virus (HIV) Infections (AIDS)
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 2
lepunafusp alfa
lepunafusp alfa [INN]
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
JCR Pharmaceuticals Co Ltd
0
catalysts
Phase 2
lepzacitinib
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
0
catalysts
Phase 2
lerapolturev
lerapolturev [INN]
Metastatic Melanoma
Istari Oncology Inc
0
catalysts
Phase 2
leronlimab
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
C-C chemokine receptor type 5
$CYDY
CytoDyn Inc.
0
catalysts
Phase 2
letetresgene autoleucel
Myxoid Liposarcoma
US WorldMeds LLC
0
catalysts
Phase 2
levothyroxine sodium
Thyquidity (levothyroxine sodium)
Hypothyroidism
Thyroid hormone receptor
$XERS
Xeris Biopharma Holdings, Inc.
0
catalysts
Phase 2
liafensine
Treatment Resistant Depression
Monoamine transporter
Denovo Biopharma LLC
0
catalysts
Phase 2
libevitug
libevitug [INN]
Hepatitis D
Huahui Health Ltd
0
catalysts
Phase 2
lidocaine SR
lidocaine
Pain
Sodium channel alpha subunit
Sustained Therapeutics Inc
0
catalysts
Phase 2
ligufalimab
ligufalimab [INN]
Myelodysplastic Syndrome (Preleukemia)
Akeso Inc
0
catalysts
Phase 2
linaprazan glurate hydrochloride
Reflux Esophagitis (Gastroesophageal Reflux Disease)
Cinclus Pharma Holding AB
0
catalysts
Phase 2
linperlisib
linperlisib [INN]
Follicular Lymphoma
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
lisocabtagene maraleucel
Breyanzi (lisocabtagene maraleucel)
Chronic Lymphocytic Leukemia (CLL)
B-lymphocyte antigen CD19
Bristol-Myers Squibb Co
0
catalysts
Phase 2
lithium citrate
Lithium Citrate (lithium citrate)
Alzheimer's Disease
Glycogen synthase kinase-3
Inositol monophosphatase 1
Medesis Pharma SA
0
catalysts
Phase 2
litoxetine
litoxetine [INN]
Stress Urinary Incontinence
Vaneltix Pharma Inc
0
catalysts
Phase 2
lixadesiran + pixofisiran
lixadesiran [INN] + pixofisiran [INN]
Basal Cell Carcinoma (Basal Cell Epithelioma)
Sirnaomics Ltd
0
catalysts
